Femasys Inc. Finance Lease, Right-of-Use Asset, Amortization
Femasys Inc. (FEMY) reported Finance Lease, Right-of-Use Asset, Amortization of $11.80 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Expense Statement
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2024-03-28
- Femasys Inc. finance lease, right-of-use asset, amortization for fiscal 2023 was $11.80K, a 35.48% decline from fiscal 2022.
- Femasys Inc. finance lease, right-of-use asset, amortization for fiscal 2022 was $18.28K, a 1.39% decline from fiscal 2021.
- Femasys Inc. finance lease, right-of-use asset, amortization for fiscal 2021 was $18.54K, a 1.41% increase from fiscal 2020.
- Femasys Inc. finance lease, right-of-use asset, amortization for fiscal 2020 was $18.28K.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|
| 2023-12-31 | $11.80K 10-K · filed 2024-03-28 |
| 2022-12-31 | $18.28K 10-K · filed 2024-03-28 |
| 2021-12-31 | $18.54K 10-K/A · filed 2023-07-24 |
| 2020-12-31 | $18.28K 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |